NIOSH Support for Conferences and Scientific Meetings (U13 Clinical Trial Not Allowed)
ID: 331936Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH), through the National Institute for Occupational Safety and Health (NIOSH), is offering the NIOSH Support for Conferences and Scientific Meetings (U13) funding opportunity to promote high-quality events focused on occupational safety, health, and associated research priorities. This cooperative agreement aims to support scientific meetings, conferences, and workshops that align with NIOSH’s mission and the National Occupational Research Agenda (NORA), with a funding limit of up to $30,000 for individual conferences, expandable to $75,000 upon prior approval. The initiative is critical for generating knowledge and facilitating communication among stakeholders regarding occupational safety challenges, particularly in light of the significant costs related to work-related injuries and illnesses. Interested applicants, including higher education institutions and nonprofits, must adhere to submission guidelines through Grants.gov or the NIH ASSIST system, with applications due by December 14, 2025. For further inquiries, applicants can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institute for Occupational Safety and Health (NIOSH), is offering the NIOSH Support for Conferences and Scientific Meetings (U13) funding opportunity to promote high-quality events focused on occupational safety, health, and associated research priorities. The program, reissuing the PAR-14-229 FOA, encourages scientific meetings that are relevant to NIOSH’s mission and the National Occupational Research Agenda (NORA). Eligible applicants include higher education institutions, nonprofits, and various government entities, with up to $30,000 available for individual conferences, expandable to $75,000 upon prior approval. Applications must demonstrate alignment with NIOSH’s strategic goals, outline potential public health impacts, and adhere to submission guidelines through Grants.gov or the NIH ASSIST system. The funding aims to generate knowledge and facilitate communication among stakeholders regarding occupational safety challenges, particularly in light of the significant costs related to work-related injuries and illnesses. The anticipated impact includes reduced occupational hazards and improved workplace practices, which is critical for worker health outcomes. The call for proposals reflects NIOSH’s commitment to innovative, evidence-based solutions addressing the modern workforce's evolving needs. The grant application process involves stringent adherence to specified instructions to ensure successful submission and funding consideration.
    Similar Opportunities
    NIOSH Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a grant opportunity titled "NIOSH Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)" aimed at supporting high-quality scientific meetings that advance research in occupational safety and health. Eligible applicants, including nonprofits without 501(c)(3) status and higher education institutions, are encouraged to submit proposals that align with NIOSH's strategic goals and the National Occupational Research Agenda (NORA), focusing on significant occupational health issues. This initiative underscores NIOSH's commitment to enhancing workplace safety through rigorous research and collaboration among experts, with a total funding amount of $500,000 available for up to five awards, each ranging from $10,000 to $20,000. Interested parties should submit their applications by December 15, 2025, and can contact Sharon Chou, Ph.D., at SChiou@cdc.gov for further information.
    NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIH Research Conference Grant (R13) to support high-quality scientific conferences that align with public health and the scientific missions of participating Institutes and Centers. This initiative encourages diverse participation and requires applicants to submit a detailed diversity plan, conference objectives, and logistical arrangements, while ensuring that costs align with actual project needs. The funding is crucial for fostering inclusive environments at scientific gatherings, with applications evaluated based on significance, innovation, approach, and diversity. Interested applicants can find more information and guidelines at the NIH website, with the application submission period opening on March 12, 2024, and closing on January 8, 2027. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is offering grants under the R13 Clinical Trial Not Allowed program to support high-quality conferences and scientific meetings that align with its mission, particularly in public health. The objective of this funding opportunity is to facilitate research exchange on FDA-related topics through symposiums, seminars, workshops, or formal meetings, while ensuring that clinical trials are not funded under this grant. This initiative is crucial for fostering scientific dialogue and collaboration, enhancing public health outcomes, and promoting compliance with federal regulations. Interested applicants, including higher education institutions and nonprofits, can apply for a total estimated funding of $1,000,000, with up to 20 awards anticipated. Key deadlines for submission are set for April and October annually through 2025, and applicants must submit a Letter of Intent eight weeks prior to their application. For further inquiries, contact Janelle Fundersburg at janelle.fundersburg@fda.hhs.gov or by phone at 301-798-2533.
    Notice of Intent to Publish a Funding Opportunity Announcement for Annual Conference in Therapeutics Development for Substance Use Disorders (U13 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for a Conference Award aimed at advancing the development of therapeutics for substance use disorders (SUDs). This initiative will solicit applications for an annual scientific meeting, with the goal of fostering collaborations and responsive projects in the field. The anticipated Notice of Funding Opportunity (NOFO) is expected to be published in Winter 2024, with applications due in early 2025, and will utilize the U13 activity code. The total funding amount is estimated at $100,000, with one award anticipated, and interested applicants should prepare for the application process ahead of the expected synopsis post date on December 18, 2024.
    AHRQ Conference Grant Programs (R13)
    Active
    Agency for Health Care Research and Quality
    The Agency for Healthcare Research and Quality (AHRQ) is offering a funding opportunity through its Conference Grant Programs (R13) to support conferences that align with its mission of improving healthcare quality, safety, accessibility, and affordability. The grants, capped at $50,000 in direct costs annually, are intended to facilitate research development, methodology, dissemination of findings, and stakeholder collaboration, with a strong emphasis on including diverse priority populations to advance health equity. Interested applicants must submit their proposals electronically via Grants.gov, ensuring a comprehensive budget and robust dissemination plans, with the application deadline set for October 31, 2026. For further inquiries, applicants can contact AHRQ at GrantQueries@ahrq.hhs.gov.
    FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a grant opportunity titled "FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)" aimed at facilitating federal financial assistance for high-quality conferences and scientific meetings that align with the FDA's mission. The program seeks to support events such as symposiums, seminars, and workshops that focus on public health issues relevant to the FDA's objectives, with an estimated total program funding of $1,000,000 and approximately 30 awards expected. Interested applicants, specifically small businesses, should note that non-domestic entities are ineligible, and applications must be submitted before the conference start date to be considered for funding. For further inquiries, applicants can contact Janelle Fundersburg at Janelle.Fundersburg@fda.hhs.gov or by phone at 301-796-2533.
    Ensuring Research Integrity - Conferences and Workshops Program (CWP)
    Active
    Office of the Assistant Secretary for Health
    The Office of the Assistant Secretary for Health is forecasting a federal grant opportunity titled "Ensuring Research Integrity - Conferences and Workshops Program (CWP)." This program aims to support the planning and execution of conferences and workshops that promote responsible research conduct and disseminate findings related to research integrity. The initiative is particularly focused on projects that include thematic conferences, skill-building workshops, and outreach events designed to foster knowledge sharing and practical strategies for enhancing research integrity. Eligible applicants include small businesses, public or nonprofit organizations, and institutions that can demonstrate a domestic benefit from their proposed activities. The grant offers funding ranging from $25,000 to $50,000, with an estimated total program funding of $100,000 and two expected awards. Interested parties should note that applications must be submitted electronically by April 9, 2025, and can direct inquiries to Armineh Ghazarian at Armineh.Ghazarian@hhs.gov or by phone at 240-453-8200.
    The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)" aimed at supporting innovative research that explores how work influences health outcomes and disparities among various populations. This initiative seeks to identify and characterize the pathways through which employment and occupational factors affect health, particularly focusing on underrepresented groups and issues related to mental health and substance use. Eligible applicants include a wide range of organizations such as higher education institutions, community-based organizations, and tribal governments, with no budget cap for proposals that reflect project needs. Applications will be accepted starting January 5, 2025, with awards expected to commence in July 2025; interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    National Center for Construction Safety and Health Research and Translation (U54)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is inviting applications for the National Center for Construction Safety and Health Research and Translation (U54), aimed at reducing work-related injuries and illnesses in the construction industry. This funding opportunity encourages multidisciplinary research and intervention strategies that focus on hazard identification, the development of safety practices, and the dissemination of best practices to enhance the health and safety of U.S. construction workers. The initiative aligns with national public health goals, including the Healthy People 2030 objectives, and emphasizes collaboration with various stakeholders to address significant health burdens in the construction workforce. The total funding available is approximately $28.75 million over five years, with individual awards capped at $5.75 million per budget year. Interested applicants must submit a Letter of Intent by November 1, 2023, and complete applications by December 1, 2023, with subsequent deadlines on October 31 in the following years until 2026. For further inquiries, applicants can contact Sharon Chiou at 304-285-6029 or via email at schiou@cdc.gov.
    Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)," aimed at supporting studies that address barriers to the adoption and sustainability of evidence-based health interventions, particularly in underserved communities. The initiative encourages research that promotes equitable access to effective practices and explores methods for discontinuing ineffective or harmful interventions, emphasizing the importance of contextual factors and multidisciplinary collaboration. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal governments, with a maximum funding amount of $275,000 and a project period of up to two years. Interested parties can find more information and submit inquiries via the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with applications due by May 7, 2025.